The largest database of trusted experimental protocols

6e10 antibody

Manufactured by Merck Group

The 6E10 antibody is a lab equipment product developed by Merck Group. It is a well-characterized monoclonal antibody that specifically recognizes the amyloid-beta protein. The 6E10 antibody can be utilized in various research applications that require the detection or quantification of amyloid-beta.

Automatically generated - may contain errors

3 protocols using 6e10 antibody

1

Immunohistochemical Detection of Amyloid-Beta

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five sections spanning the entire brain were stained with a 6E10 antibody (1:1000, Biolegend) or Congo red (Sigma) to detect Aβ plaques in the brain (the 6E10 antibody was used to stain compact and diffuse Aβ; Congo red was used to stain for compact Aβ). CAA was manually assessed in Congo red‐stained hippocampal sections under a microscope (Wilcock et al., 2006 (link)).
+ Open protocol
+ Expand
2

Alzheimer's Disease Therapeutic Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
PSM-04 was provided by Braintropia (Korea) for research purposes. BDNF was purchased from Peprotech (United States). Donepezil, 6E10 antibody, hexafluoroisopropanol (HFP), and vitamin E were purchased from Sigma Aldrich (St. Louis, MO, United States). Anti-BDNF antibody was purchased from Abcam (Cambridge, United Kingdom), and anti-Mn-SOD antibody was purchased from Merck Millipore (Darmstadt, Germany).
+ Open protocol
+ Expand
3

Characterizing Alzheimer's-Related Pathology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry and immuno uorescence were conducted to our previous methods (13) . Serial coronal brain sections (30 µm in thickness) were cut using cryostat. Five brain sections spanning the entire brain were stained with a 6E10 antibody or Congo red (Sigma) to detect Aβ plaques in the brain (6E10 antibody for compact and diffuse Aβ; Congo red for compact Aβ). Cerebral amyloid angiopathy (CAA) was manually assessed in Congo red-stained hippocampal sections under a microscope (14) . Brain sections were also incubated with anti-CD68 antibody (Abcam) and anti-glial brillary acidic protein (GFAP) antibody (Abcam) to assess the microgliosis and astrocytosis, respectively. Double immuno uorescence staining for NeuN and microtubule associated protein (MAP)-2 (Abcam) were performed to detect the neuronal loss and neurite degeneration. Apoptosis of neurons in the CA3 area of hippocampus was assessed by double-immuno uorescence staining for NeuN (Abcam) and caspase-3 (Abcam).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!